BIG PHARMA BETS ON A ONE‑VISIT CURE FOR DEPRESSION

Depression is a leading cause of disability worldwide, affecting over 300 million people. In India, millions likely live with untreated or undiagnosed depression, which increases risks of lost productivity, poor physical health and suicide. Its scale makes better treatments a public‑health priority. Current care relies on therapy and daily antidepressant pills (SSRIs, SNRIs), which help […]

BIG PHARMA BETS ON A ONE‑VISIT CURE FOR DEPRESSION Read More »